NCT06966700 2026-04-17A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Merck Sharp & Dohme LLCPhase 3 Recruiting2,400 enrolled